CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
134,016,555
Share change
+68,465,717
Total reported value
$164,829,733
Put/Call ratio
41%
Price per share
$1.23
Number of holders
87
Value change
+$84,004,120
Number of buys
50
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q4 2015

As of 31 Dec 2015, CTI BIOPHARMA CORP - COM (CTIC) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 134,016,555 shares. The largest 10 holders included BVF INC/IL, FMR LLC, Stonepine Capital Management, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Sio Capital Management, LLC, BlackRock Institutional Trust Company, N.A., DAFNA Capital Management LLC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 87 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.